| JOFTYS Glaxo Group Limited
97315733 16 Mar 2022 | on 04 Apr 2023
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | IGNYSO Glaxo Group Limited
97295867 04 Mar 2022 | on 11 Apr 2023
| Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Vaccines | | | IMNYSO Glaxo Group Limited
97295840 04 Mar 2022 | on 28 Mar 2023
| Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Vaccines | | | KLIVELDA Glaxo Group Limited
97239401 26 Jan 2022 | on 28 Feb 2023
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | HYNTRELTA Glaxo Group Limited
97235533 24 Jan 2022 | on 17 Jan 2023
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | KIXMOTA Glaxo Group Limited
97235598 24 Jan 2022 | on 14 Mar 2023
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | KYSZOLFA Glaxo Group Limited
97084340 20 Oct 2021 | on 22 Nov 2022
| The word(s) "KYSZOLFA" has no meaning in a foreign language.,Vaccines;... Class 005 Class 005 Pharmaceutical Products The word(s) "KYSZOLFA" has no meaning in a foreign language. | | | KEZAVEV Glaxo Group Limited
97063221 07 Oct 2021 | on 29 Nov 2022
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | KETSPI Glaxo Group Limited
97063224 07 Oct 2021 | on 29 Nov 2022
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | JEKTROS Glaxo Group Limited
97060754 05 Oct 2021 | on 25 Oct 2022
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | 
